HIRONIC

KIMES 2025: HIRONIC PRODUCTS SHOWCASE IN SEOULKIMES 2025 is expected to draw tens of thousands of visitors from around the globe. HIRONIC is all set to showcase its global-hit products from March 20th to 23rd.Visit us at booth A624 in COEX and experience the revolutionary MFU+RF skin rejuvenating system, NEW DOUBLO 2.0™, RF total solution system, SILKRO™, the real 300ps picolaser, PICOHI™, 3rd needle-free triple synergy injector, SYNERJET™ and even our newly launching products, firsthand. 

As a leading Korean manufacturer of medical EBD for aesthetics, with 18 years of experience and over 9,000 devices sold worldwide,  we are thrilled to announce the launch of our latest breakthrough—the 3rd Generation Needle-Free Triple Synergy Injector, SynerJet Pro.   The SynerJet Pro revolutionizes the application of medical aesthetics treatments by synergizing the effects of Microjetting, Electroporation, and Plasma technologies.  This state-of-the-art injector ensures 100% needle-free operations, reducing pain and risks associated with traditional methods. Designed for precise depth and volume control,  SynerJet Pro offers uniform delivery for consistently excellent results.   An exclusive early deal is now available for our partners who wish to pioneer the future of aesthetic treatments with us. For more details, we invite you to visit our product page: https://hironic.com/p/Synerjetpro  *Please note that this is an international informational page about product. Product indications for use and specifications may vary by country.  To obtain information relevant to your territory, kindly submit a request via the request form provided.   

HIRONIC March Distributor TrainingThe HIRONIC Distributor Training program is back for its March schedule.Enrollment is now open, and we invite all our international distribution partners to join us in this comprehensive educational initiative.This training program aims to empower your sales and marketing teams with the knowledge and skills necessary to effectively represent the HIRONIC brand and drive successful market penetration in your respective regions.Our expert instructors will guide you through interactive sessions, hands-on demonstrations, and case studies.   

The 23rd edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!   

The 22th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     

HIRONIC Co., Ltd has successfully concluded its participation in the world-renowned aesthetic medical device exhibition, IMCAS 2025, held in Paris, France, from January 30 to February 2. During the event, HIRONIC showcased its latest technological advancements, receiving significant attention from industry professionals as it aggressively pursued global market expansion with its flagship and new products. IMCAS is an international platform that annually introduces innovative aesthetic medical devices. At this prestigious venue, HIRONIC unveiled the New DOUBLO 2.0, SILKRO, and its latest device, SYNERJET. The SYNERJET, in particular, garnered significant interest from global distributors and medical professionals as a next-generation device based on needle-free injection technology. It enables faster and more efficient treatments compared to conventional injection therapies. Currently, exclusive distribution agreements are under negotiation in key markets such as the United States and Russia, signaling rapid global market expansion. The New DOUBLO 2.0, incorporating a fusion of Microfocused Ultrasound (MFU) and Radiofrequency (RF) technologies, demonstrated superior clinical efficacy over existing treatment methods and has secured certifications in multiple countries, including Thailand and Brazil. During a live demonstration session at IMCAS, Dr. Thitikom Lim from Thailand shared insights into the Triple Firm Protocol utilizing the New DOUBLO 2.0, drawing keen interest from attendees. Meanwhile, SILKRO, an RF microneedling device, also received high praise in the growing global Energy-Based Device (EBD) market. The steady increase in interest in SILKRO during the exhibition further underscores HIRONIC’s expanding global influence.Additionally, during the exhibition, HIRONIC hosted the ‘Global VVIP Partner Meeting’ to strengthen its collaborative network. Key partners from various countries, including Brazil and Thailand, attended to discuss strategic cooperation, with some being recognized as Top Partners of the Year for their outstanding contributions. A company representative stated, “IMCAS 2025 was an opportunity to confirm that our innovative technologies and products are highly competitive on the global stage.” They further emphasized, “With the exceptionally positive response to SYNERJET, we are highly optimistic about expanding into new markets and increasing sales.”

The 21st edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     

The 20th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     

On December 8, 2024, at the Grand Ballroom of the Grand InterContinental Parnas Hotel in Seoul, we had the pleasure of presenting the 'New Doublo 2.0' and 'PICOHI' at the <48th Fall International Symposium of the Korean Society for Laser Medicine and Surgery>. Notably, Dr. Lee Jae-hyuk delivered an insightful lecture titled "Essential EBD for Aesthetic Clinic Startups: HIFU + Bi-RF + NRF.“ Additionally, we hosted a social media participation event at our booth, which garnered significant interest from attendees. Thanks to your enthusiasm, we successfully concluded the event on a high note. We sincerely appreciate your continued interest and support for HIRONIC, and we look forward to further growth and innovation in the future.​ 

On December 19, 2024, the seminar on the latest skin-tightening techniques featuring the New Doublo 2.0™ was held at the Rossukon Meeting Room, Piyavate Hospital, Bangkok, Thailand. Organized by Optima Aesthetics, the event showcased cutting-edge advancements in RF-enhanced HIFU technology and attracted significant interest and enthusiasm from the attendees.   Expert-Led Sessions Esteemed speakers, including Dr. Pakamon Dechsongjarus, Dr. Wonkyo Hong, Dr. Chatbongkoch Khemacheewakul, and Dr. Tanchanok Ingpongpan, shared insights into advanced treatment protocols such as Focus Linear Techniques, Synergy Dotting Techniques, and RF-Microneedling applications.   Live Demonstration The afternoon session featured a live demonstration of the New Doublo 2.0™, highlighting its versatility and efficacy in achieving remarkable results in skin lifting, skin quality improvement, and targeted rejuvenation.   The event was met with overwhelming success, with attendees expressing great interest in the New Doublo 2.0™. The integration of RF with HIFU technology and its proven effectiveness in improving over 14 skin parameters resonated with participants. The patented safety features and customizable treatment protocols were particularly praised for addressing both patient safety and tailored care. Attendees included dermatologists, aesthetic physicians, and other medical professionals who were impressed by the transformative capabilities of the New Doublo 2.0™. Many expressed their intent to adopt the device in their practices, noting its potential to set a new benchmark in the global skin-tightening market. 

HIRONIC has been featured in the November/December issue of The Aesthetic Guide!Under the theme "Device with Synergistic Technologies Customizes Treatment from Skin to SMAS,"  The aesthetic guide highlighted our New Dublo 2.0™ as innovative device performing revolutionary treatment.Our esteemed Dr. Hanwon Ryu and Dr. Kyuhong Hwang shared insights into the diverse features and synergistic lifting technologies of the New Doublo 2.0.Discover proven results and expert insights in this latest edition. 

HIRONIC Unveils the Latest in HIFU Technology with New Doublo 2.0 at Taiwanese Dermatological MeetingTaipei, November 16, 2024  HIRONIC, a leader in medical aesthetic technology, introduced the groundbreaking New Doublo 2.0, featuring integrated Radio Frequency (RF), at the 50th Annual Meeting of the Taiwanese Dermatological Association held at the Taipei International Convention Center.The latest iteration of the popular Doublo series, the New Doublo 2.0, represents a significant advancement in High-Intensity Focused Ultrasound (HIFU) technology. Dr. Hanwon Ryu, a renowned expert in dermatological innovations, led the session titled "Breaking the Boundaries of HIFU: Introducing New Doublo 2.0 with RF for Comprehensive Multilayer Lifting – From Epidermis to SMAS."During his presentation, Dr. Ryu elaborated on the enhanced capabilities of the New Doublo 2.0, which now combines traditional HIFU with RF technology to provide a more comprehensive and effective treatment. The integrated RF module targets the epidermal and dermal layers of the skin, while the HIFU technology reaches deeper into the subcutaneous tissue and SMAS (Superficial Muscular Aponeurotic System), offering a multilayer lifting effect."This combination allows for precise and controlled skin lifting and tightening, effectively addressing the needs of patients looking for non-invasive rejuvenation treatments," explained Dr. Ryu. The New Doublo 2.0 also boasts improved patient comfort and shorter treatment times, making it a compelling choice for both practitioners and clients.The unveiling of the New Doublo 2.0 was met with positive reception from dermatologists and medical professionals attending the conference, further cementing HIRONIC's position at the forefront of innovative aesthetic solutions.​ 

HIRONIC Co., Ltd. announced that its innovative plasma device, Plasonic, has received FDA approval from the U.S. Food and Drug Administration. This marks HIRONIC’s second FDA approval following the certification of Silkro, further establishing the company's reputation for safe and effective skin aesthetic medical technology.Plasonic harnesses plasma, known as the fourth state of matter (beyond solid, liquid, and gas), which is a naturally occurring ionized energy often observed in natural phenomena. Renowned for its sterilization and regenerative properties, plasma-based skin treatments have already become mainstream across Europe.Plasonic combines two mechanisms—plasma and ultrasound—to maximize the absorption of cosmetic or skin booster ingredients. Plasma ions create a membrane potential effect on the skin, creating microchannels between skin cells, allowing ingredients to penetrate deeply and enhance the skin’s absorption, promoting aesthetic improvements. Equipped with the Plapass (plasma) and Sonopass (ultrasound) handpieces, Plasonic delivers precise and effective treatments that remove skin lesions with minimal damage, ensuring safe procedures. In tests conducted by the Korean Dermatology Research Institute, skin treated with Plasonic’s plasma showed 4.66 times greater permeability than untreated skin, validating the role of ultrasound in enhancing the penetration of active ingredients.A HIRONIC spokesperson stated, “FDA approval for Plasonic will enable HIRONIC to distinguish itself in the global skin booster market, including the United States. With this recognition of our innovative technology and safety, we are committed to providing North American customers with advanced aesthetic medical technology that guarantees both innovation and safety.”The global skin booster market, valued at $1 billion in 2022, is projected to grow at an annual rate of 10%, reaching an estimated $2.1 billion by 2030. Currently, injectables dominate over 90% of the skin booster market, but the EBD (Energy-Based Device) sector is expanding rapidly. Given the significant growth in the U.S. medspa market, HIRONIC’s FDA approval paves the way for substantial achievements in the U.S. market.​

The 19th edition of the HIRONIC GLOBAL NEWSLETTER has been released.Please send an email to marketing@hironic.com if you have any questions.Thank you!     

We are excited to announce HIRONIC’s participation in two major events this November, where our esteemed doctors will present pioneering advancements in medical aesthetics, featuring our latest technologies, the New Doublo 2.0™ and PICOHI™. <Vietnam Grand Launching>Date: 10th November 2024Venue: New World Saigon Hotel, Ho Chi Minh City, VietnamJoin us for an insightful day with our key experts:Dr. Wonkyu HongOptimal Skin Rejuvenation with New TechnologyAn exploration of the synergy between MFU Dotting and RF technology for enhanced skin rejuvenation.Dr. Thitikom LimrattanamekhaMulti-Treatment of Acne Scars in PracticeDiscover practical approaches to effectively address acne scars using our advanced methods.Dr. Jiehoon KimPicosecond Laser in Pigmentation Treatment and Skin RejuvenationAn in-depth look at the efficacy of a 300ps pulse duration laser in rejuvenating skin and treating pigmentation disorders in Asian skin types.<50th Annual Meeting of Taiwanese Dermatological Association>Date: 16th November 2024Venue: Taipei International Convention Center (TICC), Taipei, TaiwanAt this esteemed gathering, our distinguished doctors will also share:Dr. Hanwon RyuBreaking the Boundaries of HIFU: Introducing Doublo 2.0 with RF for Comprehensive Multilayer LiftingLearn about our innovative approach to lifting from the epidermis down to the SMAS layer. We invite you to experience the latest innovations in dermatological treatments and engage with leading experts in the field. Our team will be on hand to discuss how these groundbreaking technologies can elevate your practice and answer any inquiries you may have.​